Biohaven Pharmaceutical Holding Company Ltd. revenue reports
Biohaven Pharmaceutical Holding Company Ltd. financial reports, Biohaven Pharmaceutical Holding Company Ltd. annual revenue in 2024. When does Biohaven Pharmaceutical Holding Company Ltd. report revenue?
Biohaven Pharmaceutical Holding Company Ltd. total revenue, net income and dynamics of changes in US dollar today
Net revenue of Biohaven Pharmaceutical Holding Company Ltd. on 31/03/2021 amounted to 43 823 000 $. The dynamics of Biohaven Pharmaceutical Holding Company Ltd. net revenue has changed by 8 709 000 $ over the last period. These are the main financial indicators of Biohaven Pharmaceutical Holding Company Ltd.. Graph of the financial report of Biohaven Pharmaceutical Holding Company Ltd.. Information on Biohaven Pharmaceutical Holding Company Ltd. net income on the chart on this page is drawn in blue bars. The value of the "total revenue of Biohaven Pharmaceutical Holding Company Ltd." on the chart is marked in yellow.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
43 823 000 $
-
-264 968 000 $
-
31/12/2020
35 114 000 $
-
-217 736 000 $
-
30/09/2020
17 664 000 $
-
-195 189 000 $
-
30/06/2020
9 698 000 $
-
-180 934 000 $
-
30/09/2019
0 $
-
-106 167 000 $
-
30/06/2019
0 $
-
-211 070 000 $
-
31/03/2019
0 $
-
-62 304 000 $
-
31/12/2018
0 $
-
-54 750 000 $
-
Show:
to
Biohaven Pharmaceutical Holding Company Ltd. financial report charts
The dates of the latest financial statements of Biohaven Pharmaceutical Holding Company Ltd.: 31/12/2018, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Biohaven Pharmaceutical Holding Company Ltd. is 31/03/2021. Gross profit Biohaven Pharmaceutical Holding Company Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Biohaven Pharmaceutical Holding Company Ltd. is 30 961 000 $
Biohaven Pharmaceutical Holding Company Ltd. quarterly report dates
Cost of revenue Biohaven Pharmaceutical Holding Company Ltd. is the total cost of producing and distributing of products and services of a company. Cost of revenue Biohaven Pharmaceutical Holding Company Ltd. is 12 862 000 $ Total revenue Biohaven Pharmaceutical Holding Company Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Biohaven Pharmaceutical Holding Company Ltd. is 43 823 000 $ Operating income Biohaven Pharmaceutical Holding Company Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Biohaven Pharmaceutical Holding Company Ltd. is -235 673 000 $
Net income Biohaven Pharmaceutical Holding Company Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Biohaven Pharmaceutical Holding Company Ltd. is -264 968 000 $ Current assets Biohaven Pharmaceutical Holding Company Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Biohaven Pharmaceutical Holding Company Ltd. is 900 696 000 $ Total assets Biohaven Pharmaceutical Holding Company Ltd. refers to the total amount of assets owned by a person or entity. Total assets Biohaven Pharmaceutical Holding Company Ltd. is 1 003 159 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
30 961 000 $
25 146 000 $
13 420 000 $
6 640 000 $
-51 801 000 $
-154 673 000 $
-33 291 000 $
-29 784 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
12 862 000 $
9 968 000 $
4 244 000 $
3 058 000 $
51 801 000 $
154 673 000 $
33 291 000 $
29 784 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
43 823 000 $
35 114 000 $
17 664 000 $
9 698 000 $
-
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-235 673 000 $
-170 700 000 $
-163 157 000 $
-160 587 000 $
-90 456 000 $
-199 212 000 $
-54 465 000 $
-48 066 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-264 968 000 $
-217 736 000 $
-195 189 000 $
-180 934 000 $
-106 167 000 $
-211 070 000 $
-62 304 000 $
-54 750 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
107 111 000 $
73 459 000 $
57 044 000 $
42 425 000 $
9 873 000 $
21 304 000 $
7 712 000 $
8 174 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
279 496 000 $
205 814 000 $
180 821 000 $
170 285 000 $
90 456 000 $
199 212 000 $
54 465 000 $
48 066 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
900 696 000 $
603 406 000 $
708 285 000 $
362 562 000 $
423 170 000 $
474 352 000 $
227 373 000 $
272 339 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
1 003 159 000 $
686 975 000 $
782 015 000 $
424 255 000 $
439 087 000 $
490 908 000 $
245 080 000 $
290 012 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
464 714 000 $
132 149 000 $
316 231 000 $
261 061 000 $
416 574 000 $
465 739 000 $
217 407 000 $
264 249 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
47 206 000 $
44 669 000 $
23 693 000 $
19 534 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
320 111 000 $
304 167 000 $
148 069 000 $
139 092 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
72.90 %
61.96 %
60.42 %
47.96 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
-275 976 000 $
-390 370 000 $
-212 379 000 $
-35 466 000 $
118 976 000 $
186 741 000 $
97 011 000 $
150 920 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-70 128 000 $
-159 887 000 $
-46 869 000 $
-33 416 000 $
Last revenue report of Biohaven Pharmaceutical Holding Company Ltd. was 31/03/2021. According to last financial report total revenue in Biohaven Pharmaceutical Holding Company Ltd. was 43 823 000 US dollar and changed by 0% since last year. Net income in Biohaven Pharmaceutical Holding Company Ltd. was -264 968 000 $ in last quartal, net income changes to 0%.
Current cash Biohaven Pharmaceutical Holding Company Ltd. - the sum of all of the cash a company has on the date of report. Current cash Biohaven Pharmaceutical Holding Company Ltd. is 464 714 000 $
Biohaven Pharmaceutical Holding Company Ltd. stocks data
